Association of Blood Lead Levels With Mortality in Patients on Maintenance Hemodialysis (Q39976421)

16 September 2017

title

Association of blood lead levels with mortality in patients on maintenance hemodialysis (English)

1 reference

16 September 2017

Association of Blood Lead Levels With Mortality in Patients on Maintenance Hemodialysis (English)

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.10.022

28 November 2024

1 reference

Ja-Liang Lin

1

1 reference

16 September 2017

Dan-Tzu Lin-Tan

2

1 reference

16 September 2017

Ching-Wei Hsu

3

1 reference

16 September 2017

Tzung-Hai Yen

4

1 reference

16 September 2017

Kuan-Hsing Chen

5

1 reference

16 September 2017

Hsiang-Hao Hsu

6

1 reference

16 September 2017

Tai-Chin Ho

7

1 reference

16 September 2017

Kuang-Hong Hsu

8

1 reference

16 September 2017

language of work or name

English

0 references

publication date

1 April 2011

1 reference

16 September 2017

April 2011

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21435426

full work available at URL

28 November 2024

https://api.elsevier.com/content/article/PII:S0002934311000167?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.10.022

https://api.elsevier.com/content/article/PII:S0002934311000167?httpAccept=text/plain

28 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.10.022

American Journal of Medicine

28 November 2024

published in

1 reference

16 September 2017

volume

124

1 reference

16 September 2017

issue

4

1 reference

16 September 2017

page(s)

350-358

1 reference

Blood lead levels and death from all causes, cardiovascular disease, and cancer: results from the NHANES III mortality study

16 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.10.022

Blood lead below 0.48 micromol/L (10 microg/dL) and mortality among US adults

28 November 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.10.022

An epidemiological re-appraisal of the association between blood pressure and blood lead: a meta-analysis.

28 November 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.10.022

Impairment of renal function with increasing blood lead concentrations in the general population. The Cadmibel Study Group

28 November 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.10.022

A longitudinal study of low-level lead exposure and impairment of renal function. The Normative Aging Study

28 November 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.10.022

Environmental lead exposure and progressive renal insufficiency

28 November 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.10.022

Environmental exposure to lead and progressive diabetic nephropathy in patients with type II diabetes

28 November 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.10.022

Environmental lead exposure and progression of chronic renal diseases in patients without diabetes.

28 November 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.10.022

Chelation therapy for patients with elevated body lead burden and progressive renal insufficiency. A randomized, controlled trial

28 November 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.10.022

Long-term outcome of repeated lead chelation therapy in progressive non-diabetic chronic kidney diseases

28 November 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.10.022

Long-Term Changes of Plasma Trace Element Concentrations in Chronic Hemodialysis Patients

28 November 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.10.022

Blood lead in hemodialysis patients

28 November 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.10.022

Mobilization of lead from bone in end-stage renal failure patients with secondary hyperparathyroidism

28 November 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.10.022

Blood lead levels, malnutrition, inflammation, and mortality in patients with diabetes treated by long-term hemodialysis

28 November 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.10.022

Blood lead levels association with 18-month all-cause mortality in patients with chronic peritoneal dialysis

28 November 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.10.022

Environmental lead exposure and urate excretion in the general population

28 November 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.10.022

Control of dialysis by a single-pool urea model: the National Cooperative Dialysis Study

28 November 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.10.022

Cardiothoracic ratio, malnutrition, inflammation, and two-year mortality in non-diabetic patients on maintenance hemodialysis

28 November 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.10.022

Fasting glucose levels in predicting 1-year all-cause mortality in patients who do not have diabetes and are on maintenance hemodialysis

28 November 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.10.022

Recent advances in understanding the malnutrition-inflammation-cachexia syndrome in chronic kidney disease patients: What is next?

28 November 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.10.022

Air pollution and health in urban areas

28 November 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.10.022

Lead toxicity: current concerns

28 November 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.10.022

Chronic exposure to low doses of lead results in renal infiltration of immune cells, NF-kappaB activation, and overexpression of tubulointerstitial angiotensin II.

28 November 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.10.022

Mechanisms of lead-induced hypertension and cardiovascular disease

28 November 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.10.022

Lead promotes hydroxyl radical generation and lipid peroxidation in cultured aortic endothelial cells

28 November 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.10.022

Low-Level Environmental Exposure to Lead Unmasked as Silent Killer

28 November 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.10.022

Effects of N-acetylcysteine on lead-exposed PC-12 cells

28 November 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.10.022

Lead-induced hypertension. II. Response to sequential infusions of L-arginine, superoxide dismutase, and nitroprusside

28 November 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.10.022

Overproduction of reactive oxygen species in end-stage renal disease patients: a potential component of hemodialysis-associated inflammation

28 November 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.10.022

Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease.

28 November 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.10.022

Trace elements and lipid peroxidation in uremic patients on hemodialysis

28 November 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.10.022

Association of tibia lead and blood lead with end-stage renal disease: a pilot study of African-Americans

28 November 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.10.022

28 November 2024

Identifiers

1 reference

16 September 2017

1 reference